Danaher (DHR) Offering Possible 14.29% Return Over the Next 10 Calendar Days

Danaher's most recent trend suggests a bullish bias. One trading opportunity on Danaher is a Bull Put Spread using a strike $145.00 short put and a strike $135.00 long put offers a potential 14.29% return on risk over the next 10 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $145.00 by expiration. The full premium credit of $1.25 would be kept by the premium seller. The risk of $8.75 would be incurred if the stock dropped below the $135.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Danaher is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Danaher is bullish.

The RSI indicator is at 68.59 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for Danaher

Larry Culp’s General Electric Depends on Restructuring Plan
Fri, 06 Dec 2019 11:00:14 +0000
Since becoming General Electric (NYSE:GE) CEO in October 2018, Larry Culp has made the company a favorite of turnaround lovers.Source: Sergey Kohl / Shutterstock.com If you picked up some shares one year ago, you're sitting on a gain of 54%. But it's all a matter of timing. If you bought the day Culp joined, you're still down 14%.The glory days of Jeff Immelt, when this was a $30 stock and a dividend aristocrat, are gone forever. Culp has frozen pensions, leading to talk of a general "pension crisis" sweeping the world.InvestorPlace – Stock Market News, Stock Advice & Trading TipsBut Culp has also remade his executive team, made hard decisions on what to keep and let new hires make forward-looking statements.From here, everything depends on execution. Hard DecisionsCulp's hardest decision may have been to let General Electric's biopharma unit go to his former employer, Danaher (NYSE:DHR). The cash is desperately needed to firm up the balance sheet, which still had $76 billion of debt on it, against a market capitalization of $94 billion, in September. * 7 Retail Stocks to Buy That Dominated Thanksgiving Shopping As I wrote in July, those numbers understate the case. The company also has $74 billion of "other liabilities" — pensions and risks from old long-term care policies — to deal with.The pension freeze helps with the former. The latter is a 25-year old legacy from former CEO Jack Welch, who took on re-insurance for long-term care policies before the cost of nursing care became apparent. Activists want Welch to turn in his retirement payout, as well as Immelt, whom I consider the greatest destroyer of shareholder value the world has ever known. It ain't happening. The New ToneThese moves have created a new tone around the company. Product rollouts are now called victories and buzzwords like "citizen developer" are gaining traction.Some analysts are coming around. Home Depot (NYSE:HD) co-founder Ken Langone says he likes General Electric again, saying Culp "is doing a hell of a job."But this is only tone. General Electric under Culp remains much as it was under Immelt and his successor, John Flannery, an industrial machine company. GE Power remains a drag on results, although the company now makes more from renewable energy equipment like wind turbines. Healthcare is mostly big machines. Boeing (NYSE:BA) remains a drag on GE Aviation, and GE Capital can no longer soften the blows.For the third quarter, General Electric reported a loss of nearly $6 billion, 69 cents per share, on revenues of $23.4 billion. Culp emphasized that losses from continuing operations were just 8 cents per share. He showed $650 million in industrial free cash flow. He also pointed to a backlog of orders that now totals $386 billion, mostly for jet engines and industrial turbines. Since then the shares are up 9%, against a 2.5% gain for the average S&P 500 stock.Not everyone is convinced. JPMorgan Chase (NYSE:JPM) analyst Stephen Tusa, who saw the Immelt disaster coming and may wear the label "GE Bear" to his grave, says General Electric is still missing targets set only in March. He believes numbers look good only because of restructured spending. The Bottom Line on General ElectricGeneral Electric remains an industrial goods company. Industrial goods are not a great business to be in. The company continues to struggle with enormous debt. The amount it will owe on those long-term care policies remains uncertain.I continue to wish Culp well, but from the sidelines. General Electric is, at best, a speculation. If you buy shares today, you're betting it can generate big profits from industrial revenue, and that it can grow. Hope is still not a plan.Dana Blankenhorn is a financial and technology journalist. His latest book is Technology's Big Bang: Yesterday, Today and Tomorrow with Moore's Law, essays on technology available at the Amazon Kindle store. Write him at danablankenhorn@gmail.com or follow him on Twitter at @danablankenhorn. As of this writing he owned shares in JPM. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Retail Stocks to Buy That Dominated Thanksgiving Shopping * 6 Manufacturing Stocks to Buy as the Economy Recovers * The 7 Best Cryptocurrencies to Buy as Blockchain Heats Up The post Larry Culp's General Electric Depends on Restructuring Plan appeared first on InvestorPlace.

Was Danaher Corporation's (NYSE:DHR) Earnings Decline Part Of A Broader Industry Downturn?
Wed, 04 Dec 2019 19:45:03 +0000
Understanding Danaher Corporation's (NYSE:DHR) performance as a company requires examining more than earnings from one…

ITT or DHR: Which Is the Better Value Stock Right Now?
Tue, 03 Dec 2019 16:40:04 +0000
ITT vs. DHR: Which Stock Is the Better Value Option?

GE Is Touting Its Health-Care Business. Wall Street Is Still Divided on the Stock.
Tue, 03 Dec 2019 16:27:00 +0000
GE hosted a health-care “teach-in” in Chicago at a medical conference, but so far it isn’t changing analysts’ minds about the stock.

GE’s Health-Care Day Will Focus on What’s Working. Here’s What You Need to Know.
Mon, 02 Dec 2019 13:07:00 +0000
General Electric’s health-case business doesn’t get a lot of attention because it is, well, healthy. Still, the operation is significant for the giant conglomerate.

Be Sociable, Share!

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.